TABLE 1.
PBS/OVA/vehicle | PBS/OVA/ BLT1i | OVA/OVA/vehicle | OVA/OVA/ BLT1i6 | |
Total IgE, ng/ml | 1814 ± 390† | 1618 ± 483 | 4101 ± 358‡ | 4167 ± 565‡ |
OVA-specific IgE, mU/ml | <10 | <10 | 30.6 ± 9.0‡ | 26.8 ± 8.8‡ |
OVA-specific IgG1, EU/ml | <10 | <10 | 1681 ± 119‡ | 1524 ± 97‡ |
Definition of abbreviations: mU/ml = ELISA mUnits/ml; OVA/OVA/BLT1i = sensitized and challenged mice followed by treatment with BLT1 antagonist; OVA/OVA/vehicle = sensitized and challenged mice followed by vehicle treatment; PBS/OVA/BLT1i = nonsensitized but challenged mice followed by treatment with BLT1 antagonist; PBS/OVA/vehicle = nonsensitized but challenged mice followed by treatment with vehicle.
Mice were sensitized and challenged as described in Materials and Methods. Serum levels of immunoglobulins were assessed 48 h after the last challenge.
Mean ± SEM.
P < 0.05. PBS/OVA/vehicle PBS/OVA/BLT1i vs. OVA/OVA/vehicle OVA/OVA/BLT1i (n = 12 in each group).